A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)

NCT06630234 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Stromal Tumor (GIST)

Interventions

DRUG: DCC-3009

Sponsor

Deciphera Pharmaceuticals, LLC